Source: Mobile Register (AL)
 

OXYCONTIN DEBATE

Sunday, February 06, 2005
By RONALD FRASER
Special to the Register

 
Thousands of people in Alabama depend on OxyContin and other prescription
pain-killers. The same drugs, however, are also popular on the black market.

 
Trouble is, the government's actions to keep OxyContin out of illegal
channels are making it more and more difficult for 48 million Americans who
suffer from chronic pain to get relief.

 
From a doctor's viewpoint, Dr. Joel Hochman, director of the National
Foundation for the Treatment of Pain, says Washington is engaged "in a
fruitless and bizarre effort to curtail the abuse of drugs" that has begun
to negatively affect "its citizens and its physicians."

 
Of the 4,383 pain management doctors listed on the DoctorsForPain.com
registry, 90 are located in Alabama. That averages out to about one
chronic-pain doctor per county, meaning the loss of a single physician can
cut off hundreds of Alabamians from access to pain care.

 
To the Drug Enforcement Administration, this fragile network of care givers
is a tempting law-enforcement target.

 
In the 1990s, the DEA began targeting doctors who treat patients with high
doses of OxyContin. To the DEA, these doctors look like potential drug
traffickers and a pipeline to the black market.

 
Pain doctors' approach to OxyContin is to prescribe increasingly high doses
until a patient's pain abates or side effects set in. Because this treatment
is still controversial among some physicians, pain practitioners are
vulnerable at trial.

 
In 1993, to bankroll the DEA's war on doctors, Con gress set up a diversion
control fund. Each year, a million doctors buy a license to prescribe
FDA-approved drugs. In 2003, this fee was doubled. The DEA now rakes in
about $130 million per year from these fees -- money that is used to hire
investigators to target physicians.

 
The agency also gets funding each year -- $54 million in 2002 -- from an
asset forfeiture fund, including assets that once belonged to physicians
prosecuted by the DEA. These two pots of money afford the agency the
financial incentives and the freedom from congressional oversight to
vigorously prosecute pain doctors.

 
The DEA monitors the prescription writing habits of all doctors, and those
prescribing high doses of OxyContin raise a red flag. Investigators go to
work: Plea bargains win testimony from former patients. Indictments are
filed.

 
Trial juries hear from DEA-hired doctors who say that the use of high levels
of OxyContin are outside the normal practice of medicine. Doctors for the
defense give contrary testimony.

 
Faced with conflicting expert testimony, lay juries tend to convict.

 
In the past three years, according to Hochman, the DEA investigated about
1,800 doctors nationwide -- 1,200 of whom lost their prescription license.

 
"When doctors are investigated by the DEA," Hochman said, "their usual
response is to cease treating pain patients." Assuming each doctor serves
300 patients, as many as 180,000 pain patients lose their care providers
each year, according to him.

 
Each publicized DEA investigation and conviction spreads fear. Other doctors
may voluntarily get out of, or decide not to go into, the practice of pain
management.

 
To catch the few bad doctors, the DEA is driving many more good ones out of
business.

 
Some patients who lose their support systems turn to the black market or
even suicide for relief.

 
Dr. Jane Orient of the Association of American Physicians and Surgeons,
believes that the DEA uses "dirty tricks" to convict doctors.

 
"Physicians are being threatened, impoverished, de-licensed and imprisoned
for prescribing in good faith with the intention of relieving pain," Orient
said. "Law enforcement agents are using deceitful tactics to snare doctors,
and prosecutors manipulate the legal system to frighten doctors who might be
willing to testify on behalf of the wrongly accused doctors."

 
In March 2004, DEA administrator Karen Tandy told Congress that her drug
warriors have "been successful in addressing OxyContin diversion, as
evidenced by a reduction in the rate of increase of OxyContin prescriptions
being written and a leveling-off of OxyContin sales."

 
But this cockeyed measure of success makes no sense. Respected experts
estimate the pain experienced by 40 percent of cancer, AIDS and terminally
ill patients already goes under-treated.

 
Thanks to DEA, Orient predicts, "If you have an operation or an acute
injury, chances are your doctor will order adequate pain medication. But if
you are one of the millions with chronic, intractable, so-called 'benign
pain,' you may be told to learn to live with it."

 
Bottom line? The loss of one Alabama pain physician will not create a ripple
in the black market. But 300 honest citizens in pain may curse the DEA's
tactics when they are told, "Learn to live with it."